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Sex hormones and gender-related differences: Their influence function characterized by glomerulosclerosis, tubular at-
on chronic renal allograft rejection. rophy, interstitial fibrosis, vascular obliterative changes,
Background. Renal hemodynamics and immune responses and an intense infiltration of mononuclear cells [1, 2].differ between males and females. Thus, sex hormones and
Many alloantigen-dependent and -independent factorsgenetically determined gender differences may determine the
have been implicated in the development of chronic re-process of chronic rejection to some extent.
Methods. Female (F) or male (M) F344 kidneys were ortho- jection [3–5].
topically transplanted into ovariectomized female Lewis recipi- Are sex hormones also involved in this process? De-
ents and were treated for 16 weeks with either estradiol, testos- spite an evident sexual dimorphism in a majority of phys-terone, or vehicle.
iological and pathophysiological conditions, most experi-Results. Testosterone treatment resulted in increased urinary
mental studies are conducted in male animals only.protein excretion independently of the donor gender, as well
as extended glomerular sclerosis, interstitial fibrosis, and severe Genetically determined factors, as well as sex hormones,
vascular lesions. Additionally, mononuclear cell infiltration was may contribute to the differences between females and
most pronounced in these animals, in parallel to an increased
males regarding the incidence and/or progression of sev-expression of intercellular adhesion molecule-1 (ICAM-1), fibro-
eral diseases [6].nectin, laminin, and transforming growth factor-b (TGF-b) in
the grafts. Estradiol treatment resulted in an improved graft Observations in both animals and humans indicate
function, reduced glomerular sclerosis, and a diminished cellu- an association between male gender and a more rapid
lar infiltration, in parallel to a reduced ICAM-1, fibronectin, progression of renal diseases, independent of blood pres-
laminin, and TGF-b expression. In animals treated with vehicle,
sure and serum cholesterol levels [7]. Glomerular hemo-the gender of the donor influenced the outcome. Grafts of
dynamics, proliferation of mesangial cells, and the extra-male origin had good graft function and histology, whereas
grafts from female donors developed severe proteinuria and cellular matrix, as well as the synthesis and release of
glomerular, interstitial, and vascular damage. cytokines, vasoactive agents, and growth factors, are in-
Conclusions. These results suggest that a protective effect volved in the progression of renal diseases. Sex hormonesof estradiol on the progression of chronic rejection exists that
exert a regulatory effect on all of these factors [7].is independent of donor gender. Additionally, a male kidney
Sexual dimorphism is the most pronounced beforemay benefit from the absence of testosterone, whereas the func-
tion of a female kidney deteriorates in the absence of estradiol. menopause, emphasizing the critical role of estrogens.
Estrogens are atheroprotective and vasoprotective and
have beneficial effects on serum cholesterol levels [8]. In
Despite the increased short-term success of clinical addition, estrogens may exert potent antioxidant actions,
transplantation during recent years, many renal allo- which may contribute to the protective effects of female
grafts are lost over the long term because of chronic gender with regards to chronic renal disease [9, 10].
rejection. Clinically, chronic kidney allograft rejection Furthermore, both clinical and experimental observa-
presents itself as a progressive deterioration of renal tions have substantiated the difference between the two
sexes in terms of the immune system. For the regulation
of immune response, gonadal steroids seem to be critical,Key words: chronic rejection, hemodynamics, growth hormones, estra-
diol, testosterone, transplantation. as gonadectomy, sex steroid replacement, and pregnancy
profoundly alter its function [11, 12].Received for publication May 28, 1998
We assumed, therefore, that sex hormones are in-and in revised form December 11, 1998
Accepted for publication December 11, 1998 volved in the development of chronic rejection of kidney
allografts. In this study, we have investigated the influ- 1999 by the International Society of Nephrology
2011
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Table 1. Hormone levels and histological results in naive ratsence of testosterone and estradiol on the development
of chronic rejection in an established rat model. To gain Estradiol Testosterone
further insights into the role of gender-related differ- Rats pg/ml
ences in renal function and/or structure, donors from
Female Lewis 47.266.1 ,1.9
both sexes were used. Female Fisher 61.569.9 ,1.9
Male Lewis 44.263.6 10.462.4
Male Fisher 40.667.6 9.364.3
METHODS
Experimental design
Naive inbred rats (200 to 220 g; Sulzfeld, Germany)
gans were removed for further analysis. Creatinine, totalwere used throughout the experiments. All animals were
cholesterol, triglycerides, estradiol, and testosterone lev-kept under standard conditions and were fed rat chow
els were determined in the serum.and water ad libitum. All experiments were approved by
a governmental committee on animal welfare.
Histological analysis
To exclude the effect of recipient gender and/or sex
One sample of the kidney was fixed in 4% neutral-hormones on graft function, in all groups, ovariecto-
buffered formalin. Paraffin sections were stained withmized female Lewis rats (LEW, RT1) were used as recip-
hematoxylin/eosin and periodic acid-Schiff reagent. Theients. Female or male Fisher (F344, RT1v1) animals
extent of glomerular sclerosis was determined in aacted as donors. In order to avoid variations in sex hor-
blinded fashion by light microscopy. Glomerulosclerosismone levels throughout estrus cycle, transplantation was
was defined as a collapse of capillaries, adhesion of theperformed in recipients and female donors only during
obsolescent segment of Bowman’s capsule, and entrap-the diestrus phase.
ment of hyaline. The percentage of sclerotic glomeruliThe renal vessels of the recipient were isolated and
(glomerulosclerosis index) was assessed (more than 200clamped, and the native kidney was removed. The left
glomeruli per kidney) [15].donor kidney was removed, cooled, and positioned or-
A more sensitive evaluation of transplant rejection isthotopically into the host. Donor and recipient renal
the Banff classification [16]. According to this classifica-artery, vein, and ureter were then anastomized with 10-0
tion, glomerular, interstitial, tubular, and vascular lesionsprolene sutures. The ischemic time ranged from 20 to
were defined and scored from 0 to 31, to produce a25 minutes in all groups. Immediately thereafter, ovariec-
numerical coding (0 to 121) of kidney damage.tomy was performed. Transplanted animals were treated
Glomerular tuft volume was determined as describedwith low-dose cyclosporine (1.5 mg/kg/day) for the first
by Weibel [17]. Using an image analysis system (Northern10 days after engraftment to suppress an initial acute
Exposure; Bio-Science, Graestad, Denmark), the meanrejection episode. The remaining native kidney was ex-
glomerular random cross-sectional areas (Am) were deter-cised on day 10.
mined in at least 50 glomeruli on histological sections. NoAnimals were divided into six groups according to the
glomerulus was counted more than once, and all levels ofgender of the donor and sex hormonal treatment: E/F,
the cortex were evenly sampled. Mean volume of capillaryestradiol treatment, female graft; V/F, vehicle treatment,
tuft was calculated using this equation: V 5 (b/k)(Am)3/2,female graft; T/F, testosterone treatment, female graft;
where k 5 1.1 is the size distribution coefficient and b 5E/M, estradiol treatment, male graft; V/M, vehicle treat-
1.38 is the shape coefficient for spheres.ment, male graft; T/M, testosterone treatment, male graft.
Following transplantation, either 25 mg/kg b-estradiol
Immunohistological analysis3-benzoate (Sigma, Deisenhote, Germany) or 0.5 mg/kg
Monoclonal antibodies against CD51 T cells (OX19),testosterone propionate (Sigma), both dissolved in ses-
monocytes/macrophages (ED-1), intercellular adhesioname oil or sesame oil alone, was given subcutaneously
molecule-1 (ICAM-1; CD54), fibronectin, and lamininevery second day (0.1 ml) until harvesting, according to
were obtained from Serotec Camon Labor-service GmbHthe methods of Sakemi et al [13, 14]. Although it was in
(Wiesbaden, Germany), secondary (rabbit antimouse)the physiological range, estradiol treatment resulted in
and tertiary antibodies (mouse APAAP) from DAKOslightly higher levels than in naive animals, whereas testos-
A/S (Hamburg, Germany).terone treatment induced similar levels (Tables 1 and 2).
Kidney pieces were snap frozen in liquid nitrogen and
Functional measurements stored at –808C. Cryostat sections (4 to 6 mm) were
stained individually with monoclonal antibodies (mouseEvery four weeks, body weight was measured, and
antirat antibodies) from the above panel using the alka-24-hour urinary protein was determined. At week 16,
line phosphatase antialkaline phosphatase (APAAP)animals were narcotized. Blood pressure was measured
in the aorta (Sirecust 404; Siemens, Germany), and or- method. Stained cells were than counted using an ocular
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Table 2. Blood pressure and serum constituents 16 weeks after transplantation
Creatinine Total
Mean arterial clearance cholesterol Triglyceride
blood pressure Creatinine ml/min/100 g Estradiol Testosterone
Group mm Hg mg/dl body wt pg/ml ng/dlmg/dl
Estradiol /female kidney (E/F) 81.566.5 0.98 60.08 0.34 60.03ac 124.563.4c 101.3618.3 76.5611.2a ,2.1
Vehicle/female kidney (V/F) 83.3614.2 1.91 60.32 0.15 60.05 155.068.6 92.8 69.3c 42.869.0c ,2.1
Testosterone/female kidney (T/F) 73.864.0 1.27 60.20 0.21 60.05 193.7631.3 108.3 610.8 33.564.0b 4.260.3ab
Estradiol/male kidney (E/M) 76.365.0 1.11 60.06 0.28 60.01 135.3610.1 76.5 616.5 94.1610.6a ,2.1
Vehicle/male kidney (V/M) 89.3618.9 1.14 60.20 0.27 60.05 133.3614.1 70.5 62.9 39.362.5 ,2.1
Testosterone/male kidney (T/M) 92.0615.0 1.77 60.38 0.16 60.05 177.0642.5 105.2 629.8 46.567.9b 5.161.0b
Groups include: E/F, estradiol treatment, female graft; V/F, vehicle treatment, female graft; T/F, testosterone treatment, female graft; E/M, estradiol treatment,
male graft; V/M, vehicle treatment, male graft; T/M, testosterone treatment, male graft.
a P , 0.05 vs. vehicle
b P , 0.05, testosterone vs. estradiol treated group
c P , 0.05, gender related differences between groups with identical treatment
grid (3400, more than 30 fields counted per section). reaction allowed to proceed (368C, 1 hr). The reaction
was stopped by heating (958C for 5 min), followed byPositive cells were expressed as mean 6 sem of cells per
field of view (c/FV). ICAM-1, fibronectin, and laminin cooling on ice.
Specific cDNA products corresponding to mRNA forwere quantitated on a 0 to 41 scale (0 5 none, 41 5
dense). transforming growth factor-b1 (TGF-b1) [19], insulin-like
growth factor-1 (IGF-1) [20], inducible nitric oxide syn-
Reverse transcriptase-polymerase chain reaction thase (iNOS) [21], and b-actin [22] were amplified using
the PCR. One microliter of the RT reaction was usedTotal RNA was extracted and used for reverse tran-
scription-polymerase chain reaction (RT-PCR). A piece for PCR, which was performed in PCR buffer [750 mm/
of graft was stored in 500 ml of cold lysis solution D liter Tris hydrochloride, pH 9.0, 200 mm/liter (NH4)2SO4,
containing 4 m guanidine isothiocyanate (Sigma), 25 mm 0.1% (wt/vol) Tween, 20 mm/liter magnesium dichloride;
sodium citrate (pH 7.0), 0.1 m b-mercaptoethanol and Dianova, Hamburg, Germany] using 0.2 mm/liter of each
0.5% sarcosyl, and was frozen in liquid nitrogen. Total deoxy-nucleoside-triphosphate, 1 mm/liter of the primers
RNA was extracted from the kidneys according to a modi- (Eurogentec, Ko¨ln, Germany), and 2.5 U thermus Aquati-
fied guanidine-isothiocyanate preparation [18]. Briefly, cus (Taq) DNA polymerase (Dianova). A Perkin-Elmer
frozen tissues were mixed with 4 ml GITC buffer (4 mol/ Thermal Cycler (Model 2400; Perkin-Elmer, Norwalk,
liter guanidine isothiocyanate; Sigma) and acid phenol- CT, USA) was used for amplification with the following
chloroform (pH 4; Sigma) and were homogenized. The sequence profile: initial denaturation at 948C for three
samples were centrifuged at 1500 g for 10 minutes at minutes, followed by 30 to 35 cycles of three temperature
208C. The supernatant was treated with an equal volume PCR (denaturing, 948C for 30 seconds; annealing, 558C
of isopropanol. The mixture was centrifuged, and the for 30 seconds; and extension, 728C for 30 seconds), end-
RNA was washed with Rneasy, Total RNA Isolations ing with a final extension at 728C for seven minutes and
Kit (Qiagen GmbH, Hilden, Germany) and stored at cooling to 48C.
–808C until further processing. RNA concentration was The amplified PCR product was identified by electro-
measured spectrophotometrically. phoresis of 10 ml sample aliquots on 1.5% agarose gel
RNA was amplified by reverse transcription (RT) with stained with 0.5 mg/ml of ethidium bromide. The sample
an Oligo(dT)12–18 primer (GIBCO/BRL, Karlsrohe, Ger- products were visualized by ultraviolet transillumination,
many). One microgram of total RNA was added to 0.5 mg and the gel was photographed. Specific products were iden-
of primer. A reaction mixture containing buffer solution tified by size in relation to a known 1 Kb oligonucleotide
[Tris hydrochloride buffer (50 mm/liter, pH 8.3), potas- DNA ladder (Gibco/BRL) run with each gel. Cytokine
sium chloride (75 mm/liter), magnesium dichloride (5 mm/ cDNA was semiquantitated by densitometric comparison
liter), dithiotreitol (5 mm/liter); GIBCO/BRL], adeno- with b-actin (internal control) from the same sample
sine triphosphate, thymidine triphosphate, guanosine tri- after the positive image was digitized for computerized
phosphate, and cytosine triphosphate each in a concen- densitometry. The results are given as the ratio of inten-
tration of 0.2 mm/liter (deoxynucleoside triphosphates sity of growth factors or iNOS to b-actin mRNA 6 sem.
from Boehringer Mannheim GmbH, Mannheim, Ger-
Statistical analysismany), recombinant ribonuclease inhibitor ([0.5 ml, 40
U/ml; Promega), and reverse transcriptase (0.5 ml of 200 Data are expressed as mean 6 sem. Parametric data
were compared using one-way analysis of variance, fol-U/ml M-MLV; Gibco/BRL) was added and the first chain
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Fig. 1. Changes in body weight. *P , 0.05 vs.
vehicle; ‡P , 0.05 vs. estradiol treated group;
§P , 0.05 indicate gender-related differences
between groups with identical treatment. Con-
secutive bar graphs in each group of four bar
graphs refer to 4, 8, 12, and 16 weeks after
transplantation.
lowed by multiple pair-wise comparisons according to Proteinuria
the Newman–Keuls test. Nonparametric data were Four weeks after transplantation, proteinuria was min-
tested using the Kruskal–Wallis one-way analysis of imal in all groups (Fig. 2). At week 8, proteinuria devel-
ranks. oped in testosterone-treated animals. This high-protein
The impact of the donor gender was determined in loss was followed by a decrease—in some cases dra-
each treatment group with the Student’s t-test. Nonpara- matic—in body weight after week 12 and even preterm
metric data were analyzed using the Mann–Whitney death of some animals (N 5 3). In contrast, estradiol
analysis of ranks. A P of less than 0.05 was accepted as treatment allowed only a slight increase in protein excre-
tion throughout the experiment. There was a tendencystatistically significant [23].
toward increased urinary protein loss in animals that had
received a male kidney (E/M) as compared with those
RESULTS with a graft of female origin (E/F). Interestingly, in vehicle-
treated animals, proteinuria significantly differed accordingAnimals
to the origin of the kidney. Animals with a female kidney
The body weight of estradiol-treated animals remained
(V/F) became proteinuric similar to the testosterone-
constant during the period observed. In all other groups, treated groups, whereas rats with a male kidney (V/M)
the body weight increased after transplantation (Fig. 1). did not develop severe proteinuria.
Testosterone treatment resulted in a continuous increase
in growth up to 12 weeks post-transplant, followed by a Serum constituents and blood pressure at week 16
decrease noted at week 16. The weight of the vehicle- In testosterone-treated (T/F, T/M) groups, serum cre-
treated animals was similar until week 8, followed by a atinine was elevated and creatinine clearance decreased
further increase in recipients of a male (V/M) and a (Table 2). Similar levels were noted in vehicle-treated
decrease in recipients of a female graft (V/F). animals with a graft of female origin (V/F). Furthermore,
The kidney weight/body weight ratio (KW/BW) was testosterone treatment was associated with slightly higher
higher in the groups with a male kidney, as compared serum cholesterol levels.
with the smaller KW/BW ratio observed in estradiol Estradiol lowered serum cholesterol and serum creati-
(E/F)- or vehicle (V/F)-treated animals with a female kid- nine and improved creatinine clearance. Similar results
ney. Testosterone treatment (T/F) significantly increased were noted in the vehicle-treated rats with a male graft
the KW/BW ratio to the level observed in groups with (V/M).
Serum estradiol levels were significantly higher in thea kidney of male origin (Table 3).
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Table 3. Kidney weights and group size
Left recipient Right recipient Kidney weight/ Right donor Transplanted Kidney weight/
Group N kidney in mg kidney in mg body weighta kidney in mg kidney in mg body weightb
Estradiol/female kidney (E/F) 6 738 644 623629 0.0060 1020649 1150 668 0.0050
Vehicle/female kidney (V/F) 6 760 633 650628 0.0060 1007647 1165 6101 0.0049
Testosterone/female kidney (T/F) 6 848633 664624 0.0062 982654 1610674 0.0058
Estradiol/male kidney (E/M) 8 701 618 737621 0.0064 896618 1303658 0.0058
Vehicle/male kidney (V/M) 5 685 626 780667 0.0067 905643 15806235 0.0056
Testosterone/male kidney (T/M) 6 712612 754626 0.0067 886632 13966174 0.0055
Left recipient kidney weight was determined at the time of transplantation; right recipient kidney weight at day 10; donor right kidney weight at the time of
transplantation; weight of the transplanted kidney at the time of harvesting. Abbreviations are: E/F, estradiol treatment, female graft; V/F, vehicle treatment, female
graft; T/F, testosterone treatment, female graft; E/M, estradiol treatment, male graft; V/M, vehicle treatment, male graft; T/M, testosterone treatment, male graft.
a Kidney weight was defined as the weight of left and right recipient kidneys determined as described above. Body weight was measured at the time of nephrectomy
(day 10)
b At the time of harvesting
Approximately one half of the glomeruli were sclerotic,
and were associated with generalized interstitial fibrosis
and tubular damage. Severe vascular changes consisting
of more than 25% narrowing of the vascular luminal
area by intimal thickening were typical for testosterone
treatment. Similar findings developed in vehicle-treated
rats with a female kidney (V/F), however, they were to
a lesser extent.
On the other hand, in vehicle-treated rats with a male
kidney (V/M) and estradiol-treated animals, glomerular
sclerosis remained below 20%. This was accompanied
by a significantly lower degree of interstitial fibrosis and
only minimal vascular sclerosis.
In male kidneys, glomerular tuft volume was signifi-
cantly larger in testosterone (T/M)-treated animals than
in estradiol (E/M)- or vehicle (V/M)-treated groups. In
female kidneys, there was a tendency toward increased
glomerular tuft volume in vehicle (V/F)- and testoster-
one (T/F)-treated groups, as compared with animals
treated with estradiol (E/F). In the estradiol-treated
Fig. 2. Changes in urinary protein excretion during the course of the groups, animals with a kidney of female origin (E/F) hadexperiment at (h) four weeks and (j) 16 weeks. *P , 0.05 vs. vehicle;
significantly smaller glomerular tuft volume than animals‡P , 0.05 vs. estradiol-treated group; §P , 0.05 indicate gender-related
differences between groups with identical treatment. with a kidney of male origin (E/M).
Mononuclear cell infiltrates were apparent in all
groups. The cellular infiltration was most intense in inter-
stitial areas, particularly around vessels and glomeruli.estradiol-treated groups as compared with the decreased
Only monocytes/macrophages were present within thelevel observed in the other treatment groups. Testoster-
glomerular tuft. Cellular infiltration was diffuse and mostone was only measurable in sera of testosterone-treated
pronounced in grafts following testosterone treatment.animals.
Leukocytes localized predominantly in perivascular ar-The mean arterial blood pressure was low and did not
eas. Similarly, a high number of leukocytes were noteddiffer between the groups.
in both vehicle-treated groups. However, only a small
Histology and immunohistology proportion of the infiltrating cells was noted around the
vessels. In contrast to proteinuria or histology, in vehicle-Histology and immunohistology of the kidneys har-
treated groups, gender of the donor did not affect cellularvested at the age of transplantation did not differ be-
infiltration. Estradiol treatment significantly reduced thetween male and female animals and appeared to be com-
number of lymphocytes and monocytes/macrophages inpletely normal (Table 4). However, there were marked
the grafts.differences in transplanted kidneys at the end of the
The presence of leukocytes was associated with denseexperiment. Testosterone treatment resulted in severe
morphological alterations typical for chronic rejection. expression of ICAM-1, fibronectin, and laminin. The
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Table 4. Summary of histological and immunohistological analysis
Monocytes/
Glomerular Lymphocytes macrophages ICAM-1 Fibronectin Laminin
Glomerulosclerosis Banff score tuft volume
Group % 0–121 310 6 lm3 0–41cells/FV
Estradiol/female kidney (E/F) 15.0 62.2 3.5 60.3c 1.8960.24c 45.163.8 35.960.8ac 1.560.3a 1.060.5a 1.360.3
Vehicle/female kidney (V/F) 41.6 610.9c 6.361.1 2.3560.31 57.066.0 59.761.0c 2.560.3 2.6 60.2 1.8 60.2
Testosterone/female kidney (T/F) 49.8610.3b 7.861.0b 2.7860.25 66.5 66.3b 55.861.0abc 2.860.2b 3.560.3b 2.360.2b
Estradiol/male kidney (E/M) 17.7 63.6 2.7 60.8 2.4860.11a 50.862.8a 39.660.2a 1.560.2a 2.460.2 0.9 60.3
Vehicle/male kidney (V/M) 19.1 63.1 3.3 60.8 2.5160.17 73.769.4 62.960.1 2.360.3 3.0 60.6 1.860.3
Testosterone/male kidney (T/M) 57.869.9ab 8.660.6ab 3.0360.12a 80.467.6b 64.960.6ab 2.860.2b 3.360.2 2.2 60.5
Abbreviations are: FV, field of view; E/F, estradiol treatment, female graft; V/F, vehicle treatment, female graft; T/F, testosterone treatment, female graft; E/M,
estradiol treatment, male graft; V/M, vehicle treatment, male graft; T/M, testosterone treatment, male graft.
a P , 0.05 vs. vehicle
b P , 0.05 testosterone vs. estradiol treated group
c P , 0.05 indicate gender related differences between groups with identical treatment
expression of these molecules was most pronounced in particularly in donors over 30 years of age and male
testosterone- and vehicle-treated groups and paralleled recipients [7]. Although the gender of the recipient seems
the intense leukocyte infiltration in these grafts. ICAM-1 to have little or no effect on one-year outcome, a better
was predominantly up-regulated in small vessels, glomer- long-term graft survival has been reported in female
uli, and tubules. In contrast, estradiol reduced ICAM-1, recipients [24].
fibronectin, and laminin expression in the transplanted However, in these studies, the influence of sex hor-
kidneys. mones could not be excluded and may substantially con-
tribute to the worse outcome of female grafts, particu-
Reverse transcriptase-polymerase chain reaction larly if transplanted into males. In our experiments,
The expression of the growth factor TGF-b in the recipient gender was identical in all groups. Graft func-
grafts was most pronounced following vehicle treatment tion was influenced by sex hormone substitution and
(Fig. 3A). Similar levels were noted in testosterone- donor gender alone. Renal function declined in kidneys
treated groups. Estradiol treatment significantly de- of female origin more rapidly in the absence of estradiol.
creased the expression of TGF-b. There was no differ- In contrast, kidneys derived from male donors benefited
ence regarding of the origin of the kidney in any group. primarily from the lack of testosterone and not as much
However, donor gender-related differences were noted by estradiol substitution.
in the expression of IGF-1 (Fig. 3B). In grafts of male What is different between the donors? Male kidneys
origin (E/M, V/M, T/M) and in female grafts subse- are bigger and may have more nephrons. Brenner and
quently treated with estradiol (E/F), the expression of Milford suggested that the diminished long-term survival
IGF-1 was high and similar in all treatment groups. IGF-1 of kidneys from female donors may be explained by a
mRNA expression was lower in female grafts following mismatch between donor nephron supply and the recipi-
vehicle treatment (V/F) and was lowest in kidneys of ent’s functional demand [25]. Supporting this hypothesis,
female origin treated with testosterone (T/F). the preservation of an additional kidney ameliorates graft
The renal expression of iNOS mRNA was similar in all function [26], whereas the reduction of kidney mass ac-
treatment groups independent of kidney origin (Fig. 3C). celerates the functional and morphological deterioration
of both allografts and isografts [27]. If the female kidney
has fewer functioning nephrons, this may have contrib-DISCUSSION
uted to the worse outcome of our vehicle-treated animalsIn our experiments, testosterone treatment enhanced
with a kidney of female origin as compared with vehicle-the pace of chronic rejection in renal allografts. By con-
treated animals with male kidneys. However, estradioltrast, estradiol exerted a beneficial influence on this pro-
prevented the development of gender-related differ-cess. We also demonstrated the influence of donor gen-
ences. This indicates that estradiol deficiency may con-der on the long-term outcome.
tribute to the worse outcome of the female kidney fol-What is the impact of gender and sex hormones in
lowing transplantation and that estradiol protects againstrenal transplantation? How do our data correlate to clini-
this process. However, the results concerning gender-cal data? It is difficult to evaluate the influence of donor
related differences in the number of glomeruli are con-or recipient gender in clinical settings, as a broad latitude
tradictory in both human and animal studies [7]. Theof other factors influences graft outcome. However, in
greater kidney weight of males is influenced by andro-studies evaluating large numbers of well-matched pa-
tients, a shorter survival of female kidneys was observed, gens, which increase cortical volume by inducing proxi-
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Fig. 3. Growth factor/b-actin expression in the graft. *P , 0.05 vs.
vehicle; ‡P , 0.05 vs. estradiol-treated group; §P , 0.05 indicate gender-
related differences between groups with identical treatment. (A)
TGF-b1. (B) IGF-1. (C) iNOS.
mal tubular cell hypertrophy; this may account for a measurement, intraglomerular pressure differences be-
tween the groups cannot be excluded as a cause for themajority of gender-related differences in kidney size and
weight [28]. This is supported by the same kidney to body disparity of renal injury between the groups.
It has been suggested that glomerular hypertrophyweight ratio of female kidneys in testosterone-treated
recipients (T/F) and male kidneys in estradiol-treated may contribute to the development of glomerular injury
by increasing glomerular wall tension [32]. In our experi-ones (E/F) in our experiment. Although the kidney to
body weight ratio was the same, renal function was far ment, supporting this hypothesis, an increased glomeru-
lar volume was associated with the increased glomerularworse in testosterone-treated animals. We therefore as-
sume that hormones are more important than renal mass. damage noted following testosterone treatment. In the
female graft, the absence of estradiol, as noted in theThe increase in the glomerular capillary pressure has
been linked to hyperfiltration-induced glomerular injury vehicle-treated group, also increased the glomerular tuft
volume and glomerular damage.and progressive decline in renal function [29]. Munger
and Baylis demonstrated that a male kidney is more It has been demonstrated that diet influences the pro-
gression of glomerular injury. Dietary protein restrictionvasodilated than a female one, and total vascular resis-
tance per glomerulus is substantially higher in females protects and high dietary protein intake exacerbates glo-
merular injury. The mechanisms by which protein intakethan in males. Sex hormones may be involved in this
process because ovariectomy shifted renal hemodynam- may reduce the pace of renal decline include the reduc-
tion of capillary glomerular pressure [33] and many non-ics to that of intact males and castration to that of intact
females [30, 31]. As we did not include intraglomerular hemodynamic effects such as decreased expression of
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the growth factors TGF-b or platelet-derived growth tors, and cytokines and augments leukocyte adhesion
and their immigration into the graft. The reduction offactor [34]. In our experiments, testosterone treatment
significantly increased the body weight, and the increased these factors efficiently prolongs graft survival or reduces
the intensity of rejection. Estrogens may improve kidneyfood and protein intake may have contributed to the
functional decline and the increased TGF-b expression function by influencing these factors, as estradiol treat-
ment decreases the level of circulating P-selectin levelsobserved. Low protein intake may, in part, be responsi-
ble for the improved renal function in estradiol-treated [39] and the expression of endothelial vascular cell adhe-
sion molecule (VCAM-1) and ICAM-1 [40]. This mightrats. However, the differences noted in vehicle-treated
groups seem to be independent of body weight and food in part be mediated by a calcium channel blocker effect
of estradiol [41]. In addition, extracellular matrix pro-intake. The function of these grafts of female origin was
worse, despite the lower body weight of the animals. In teins may also play a role in specific tissue targeting of
mononuclear cells, as graft-infiltrating leukocytes local-contrast, the higher body weight of vehicle-treated rats
with a male kidney had no influence on graft function, ize selectively in fibronectin-rich interstitial and perivas-
cular areas of cardiac allografts [42]. On the other hand,underlining the difference between kidneys of female
and male origin. One of the reasons for this disparity macrophages were identified as the principal source of
locally expressed fibronectin [43]. In our study, estradiolmay be the different response of the kidney to increased
body weight. Female kidneys increased their mass much treatment reduced the infiltration of mononuclear cells
in parallel with decreased expression of ICAM-1, fibro-less than male kidneys if the recipient was treated with
vehicle alone. Therefore, the kidney to body weight ratio nectin, and laminin in the graft, and may contribute to
the better outcome of these grafts. In all other groups,was far higher for male kidneys than for female ones at
the time of harvesting, disregarding similarly sized donor increased cellular infiltration was observed in parallel to
increased expression of ICAM-1, fibronectin, and lami-kidneys. We therefore conclude that male and female
kidneys respond differently to growth hormones (GHs). nin, regardless of donor gender. Therefore, other factors
seem to be responsible for the gender-related differencesOther mechanisms contributing to the effects of the
donor gender include the possibility that female kidneys noted in vehicle-treated animals.
Transforming growth factor-b is thought to play anare more antigenic or more susceptible to ischemic in-
jury, immunological rejection, or cyclosporine A (CsA) important role in chronic allograft rejection. TGF-b is a
potent chemotactic agent for fibroblasts, controls the pro-nephrotoxicity [24]. Sex hormones influence both hu-
moral and cellular immune response. Many studies have duction of extracellular matrix proteins, and inhibits the
degradation of newly formed matrix proteins [2]. Thedemonstrated that immunoglobulin levels are higher in
females than in males, and this difference is obviously increased expression of this growth factor may contribute
to the severe chronic rejection noted in testosterone- anddetermined by sex hormones [11]. The sexual dimorphism
in cellular immunity is also evident [11]. Androgens seem vehicle-treated grafts. The protective effect of estradiol
may in part be mediated by the decreased gene expres-to exert immunosuppressive properties. When using fully
allogeneic skin grafts and CsA immunosuppression, sion of TGF-b. The effect of sex hormones on renal tissue
is not known. Sex hormones have been demonstratedadult males accept skin grafts for a significantly longer
period (more than 35 days) than females (less than 11 to modulate growth factor levels in nonrenal tissues.
Estradiol increased the synthesis and release of TGF-bdays) [35]. The data concerning the effects of estrogens
on the immune system are contradictory. Estrogens may in cell lines from female reproductive organs or osteosar-
coma cells [44, 45]. Similarly, testosterone stimulates theenhance immune responsiveness, as indicated by an in-
creased mitogen assay and plaque-forming cell response synthesis and release of TGF-b in nonrenal tissues [46].
In our experiment, estradiol treatment decreased theat proestrus [36]. On the other hand, exogenous excess
estrogen is associated with a depression of mitogen- renal expression of TGF-b, and this effect may contrib-
ute to the better long-term outcome of these grafts.induced lymphocyte transformation, as was demon-
strated in a study in women taking oral contraceptives Insulin-like growth factor-1 (IGF-1) appears to be a
weak mitogen and sclerosis-inducing agent [2]. IGF-1[37]. Moreover, castration shortens skin graft rejection
time in both male and female mice, suggesting that a accelerates recovery in animal models of ischemic or
toxic acute renal injury [47], improves early function ofreduction of sex steroids activates the cell-mediated im-
mune response [38]. In our study, graft function was not rat kidney isografts, and attenuates the course of delayed
graft function in a canine autotransplantation model [48].improved by the immunosuppressive effect of testos-
terone. IGF-1 is the major GH-dependent GH, and estradiol is
known to increase GH levels [13]. In our experiments,After ischemic injury, one of the earliest events is the
interaction of circulating mononuclear cells with graft sex hormones influenced the renal expression of IGF-1
in female but not in male kidneys. The decrease in IGF-1endothelium. The activation of endothelial cells induces
the expression of adhesion molecules, chemotactic fac- noted in the grafts of vehicle- and testosterone-treated
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animals may be responsible for the worse outcome of absence of testosterone, whereas estradiol seems essen-
tial for appropriate function of the female kidney.the kidneys of female origin in the absence of estradiol.
The increased renal IGF-1 expression noted in estradiol-
treated animals may protect the female kidney and con- ACKNOWLEDGMENTS
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